Prof Louise Serpell from the University of Sussex to investigate what triggers the first stages of protein misfolding in Alzheimer’s disease
The pharmaceutical company, Biogen, announced this week that it will stop developing and marketing the Alzheimer’s drug aducanumab (commercially known as Aduhelm). Aducanumab is designed to target and clear amyloid, one of the hallmark proteins that builds up in the brains of people with Alzheimer’s, at an early stage of the disease. This is similar…
Five cases of Alzheimer’s disease are believed to have arisen as a result of medical treatments decades earlier, according to a new study.
On International Day of Education, we’re sharing information we hope answers a common question we get about dementia risk, to raise awareness of factors that do and don’t contribute to our likelihood of developing diseases like Alzheimer’s. Many people worry about developing a disease like Alzheimer’s and want to know what things can increase their…
Detecting Alzheimer’s disease using a blood test could be just as accurate as standard lumbar punctures, study shows
Researchers have found that a blood test for Alzheimer’s could detect the disease as accurately as standard lumbar punctures.
Prof Nigel Hooper and his team of researchers at the University of Manchester are investigating a potential new treatment for Alzheimer’s disease.
Researchers at King’s College hospital are investigating a new way to look at the brain that could potentially predict the development of neurodegenerative diseases.
The festive season can be a wonderful time to share food, exchange presents and spend quality moments with your loved ones. But Christmas can have so much more meaning when we choose to give something back to a cause close to our hearts. We know that if nothing changes, 1 in 2 people will have…
What to lookout for if you’re worried about your loved ones and dementia this Christmas: Dr Tim Rittman explains the early signs and what to do next.
This week, we published our Annual Report for the 2022/23 financial year, and I couldn’t be more excited to reflect on such a momentous year for progress, both in dementia research and at Alzheimer’s Research UK.